Mogamulizumab Biosimilar – Anti-CCR4, CD194 mAb – Research Grade

Reference:
Product nameMogamulizumab Biosimilar - Anti-CCR4, CD194 mAb - Research Grade
SourceCAS 1159266-37-1
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsMogamulizumab,AMG-761,KW-0761,CCR4, CD194,anti-CCR4, CD194
ReferencePX-TA1258
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Mogamulizumab Biosimilar - Anti-CCR4/CD194 mAb - Research Grade

General information on Anti-CCR4/CD194[Homo sapiens] (Mogamulizumab) Monoclonal Antibody

Mogamulizumab targets CC chemokine receptor 4 (CCR4) and is used for the treatment of Mycosis Fungoides (MF) and Sézary Syndrome (SS) which are subtypes of cutaneous T-cell lymphoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Mogamulizumab Biosimilar – Anti-CCR4, CD194 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Stable Isotope Labelled Mogamulizumab Biosimilar – Anti-CCR4/CD194 mAb – Research Grade
SIL

Stable Isotope Labelled Mogamulizumab Biosimilar – Anti-CCR4/CD194 mAb – Research Grade

PX-TA1258-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products